Although platelets are critically involved in thrombosis and hemostasis, experimental and
clinical evidence indicate that platelets promote tumor progression and metastasis through a …

Platelets, involved in the whole process of tumorigenesis and development, constantly
absorb and enrich tumor-specific substances in the circulation during their life span, thus …

Using kernel machine learning (ML) and random optimization (RO) techniques, we recently
developed a set of venous thromboembolism (VTE) risk predictors, which could be useful to …

Cancer patients are at higher risk for venous thromboembolism (VTE). Several risk
assessment models (RAM), including the Khorana and COMPASS-CAT, were developed to …

Galectins are carbohydrate-binding proteins that regulate many cellular functions including
proliferation, adhesion, migration, and phagocytosis. Increasing experimental and clinical …

Background The risk of thromboembolic events is higher among cancer patients, especially
in patients undergoing chemotherapy. Cisplatin-based regimens claim to be associated with …

In this study, a series of 2-and/or 3-substituted juglone derivatives were designed and
synthesized. Among them, 9, 18, 22, 30, and 31 showed stronger inhibition activity against …

Background Venous thromboembolic events (VTE) are commonly encountered in patients
with lymphoma. Several risk assessments models (RAM) had attempted to identify higher …

Background: A majority of patients included in risk assessment models (RAMs) developed to
predict venous thromboembolic events (VTE) in lymphoma were non-Hodgkin lymphoma …

Malignancy, including testicular tumors, significantly increases the risk of venous
thromboembolism (VTE). In this study, we search for predictors that may help identify …